Welcome to our dedicated page for Nature's Sunshine Products news (Ticker: NATR), a resource for investors and traders seeking the latest updates and insights on Nature's Sunshine Products stock.
Nature's Sunshine Products Inc. (NASDAQ: NATR) is a leading natural health and wellness company that manufactures and markets an extensive range of high-quality nutritional and personal care products. Founded in 1972, the company has established itself as a pioneer in the health and wellness industry, offering products such as tablets, encapsulated herbal products, natural vitamins, food supplements, skin care items, and other complementary products.
The company operates on a direct-selling model and has a significant presence in multiple international markets, including but not limited to the United States, South Korea, Mexico, Venezuela, Japan, Brazil, Canada, Central America, Colombia, Ecuador, Peru, the United Kingdom, Israel, and Chile. Additionally, it exports its products to countries such as Argentina, Australia, Malaysia, New Zealand, Norway, and the Russian Federation.
Nature's Sunshine focuses on various health categories, including weight management, general health, cardiovascular health, digestive health, immune support, and personal care. The company's operations are divided into four main segments: Asia, Europe, North America, and Latin America, with Asia being the key revenue-generating market.
Recent achievements highlight the company's robust financial performance. In the latest fiscal reports, Nature's Sunshine recorded net sales up by 12% to $116.5 million, with a 14% increase in constant currency. The third quarter of 2023 saw a GAAP net income rise to $3.1 million and a 50% increase in Adjusted EBITDA to $10.3 million. The company's CEO, Terrence Moorehead, emphasized strong growth in both the Asia/Pacific and North American markets, which contributed to a 12% and 11% increase in local currency sales, respectively.
Nature’s Sunshine's gross margin improved by 150 basis points to 73.1% in Q3 2023 compared to the previous year. These improvements were attributed to market mix enhancements, price increases, and margin improvement initiatives. Selling, general, and administrative expenses (SG&A) rose to $41.3 million due to increased service fees in China, compensation, and investments in digital growth and strategic initiatives.
The company also announced a series of conference calls to discuss its quarterly and annual financial results, providing transparency and updates to shareholders and potential investors. Nature’s Sunshine’s commitment to high-quality, safe, and effective products is evident through its state-of-the-art manufacturing facilities, ensuring products meet the highest standards.
The company's outlook for the future remains positive, with expectations for continued growth in net sales and adjusted EBITDA, driven by strategic initiatives and digital investments designed to enhance market presence and customer engagement.
Nature’s Sunshine Products (NASDAQ: NATR) will host a conference call on May 9, 2023, at 5:00 p.m. Eastern time to discuss its financial results for the first quarter ended March 31, 2023. The call will feature CEO Terrence Moorehead and CFO Shane Jones, followed by a Q&A session. Investors can join the call by dialing 1-888-886-7786 for toll-free access or 1-416-764-8658 internationally. A live broadcast of the call will be available on the Nature's Sunshine website, with a replay available until May 23, 2023.
Nature’s Sunshine Products, Inc. (NATR) reported its financial results for Q4 and the full year 2022, indicating a decrease in net sales and income compared to 2021. Fourth-quarter net sales dropped to $102.7 million, down 6.4% in constant currency, while GAAP net income fell to $2.1 million, or $0.10 per share, from $13.8 million, or $0.67 per share in Q4 2021. Full-year net sales were $421.9 million, down 5.0%, with a net loss of $0.4 million, or $(0.02) per share. Adjusted EBITDA for the year decreased to $32.0 million from $49.4 million. Management remains optimistic about growth strategies for 2023.
Nature’s Sunshine Products, Inc. (NASDAQ: NATR) has announced a conference call scheduled for March 15, 2023, at 5:00 p.m. Eastern time. This call will address the company’s financial results for Q4 and the full year ending December 31, 2022. CEO Terrence Moorehead and CFO Shane Jones will lead the discussion, followed by a Q&A session. A press release with financial results will precede the call. Investors can access the live broadcast and replay through the company’s website. Nature's Sunshine operates in the health and wellness industry, distributing products across more than 40 countries, focusing on quality and safety.
Nature's Sunshine Products, Inc. (NASDAQ: NATR) has appointed Shane Jones as Chief Financial Officer, effective December 30, 2022. With over 25 years of finance experience, Jones previously held CFO roles at West Marine, 1-800 Contacts, and Backcountry.com, among others. He joins from FullSpeed Automotive. CEO Terrence Moorehead expressed confidence in Jones's ability to drive growth and operational efficiencies. Interim CFO Jonathon Lanoy will transition to Senior VP of Finance and Corporate Controller. Nature's Sunshine markets nutritional products in over 40 countries, emphasizing quality and efficacy.
Nature’s Sunshine Products reported third-quarter 2022 financial results, with net sales of $104.5 million, down from $114.7 million a year ago. GAAP net income was $0.2 million, or $0.00 per share, compared to $5.5 million, or $0.24 per diluted share last year. Adjusted EBITDA fell to $6.8 million from $12.9 million. The company faced challenges including inflation and foreign exchange impacts, which decreased gross margins by 300 basis points. Management aims to achieve $10-$12 million in cost savings over the next 18 months.
Nature's Sunshine Products (NASDAQ: NATR) announced a conference call scheduled for November 3, 2022, at 5:00 p.m. Eastern Time to discuss its third-quarter financial results, ending September 30, 2022. The call will feature CEO Terrence Moorehead and Interim CFO Jon Lanoy, followed by a Q&A session. Participants can join via a toll-free number or watch the live broadcast online. A replay will be available from 8:00 p.m. Eastern Time on the same day until November 17, 2022. Nature's Sunshine is renowned for its high-quality herbal and nutritional products, with a presence in over 40 countries.
Nature's Sunshine Products (Nasdaq: NATR) announced that its CFO, Joseph Baty, will retire on September 30, 2022. Jonathan Lanoy, the Corporate Controller and Vice President of Finance, has been appointed as Interim CFO until a permanent successor is found. CEO Terrence Moorehead acknowledged Baty's contributions to the company, highlighting improvements in financial operations. Nature's Sunshine, which operates in over 40 countries, manufactures high-quality natural health products in its own facilities, ensuring safety and efficacy.
FAQ
What is the current stock price of Nature's Sunshine Products (NATR)?
What is the market cap of Nature's Sunshine Products (NATR)?
What does Nature's Sunshine Products Inc. do?
What are the main health categories that Nature's Sunshine focuses on?
In which regions does Nature's Sunshine operate?
How is Nature's Sunshine’s financial performance?
What are the key revenue-generating markets for Nature's Sunshine?
What recent achievements has Nature's Sunshine made?
How does Nature's Sunshine ensure the quality of its products?
What strategic initiatives is Nature's Sunshine focusing on?
What is Nature's Sunshine's outlook for the future?
How can I get more information about Nature’s Sunshine?
